Picture of Hyloris Pharmaceuticals SA logo

HYL — Hyloris Pharmaceuticals SA News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapNeutral

Brief: Hyloris Successfully Raises EUR 15.0 Mln In An Equity Offering

April 1 (Reuters) - Hyloris Pharmaceuticals SA  HYL.BR :
    * HYLORIS SUCCESSFULLY RAISES EUR 15.0 MILLION IN AN EQUITY
OFFERING BY MEANS OF A PRIVATE PLACEMENT VIA AN ACCELERATED
BOOKBUILD OFFERING
    * WILL USE NET PROCEEDS OF OFFERING PRIMARILY TO FUND
DEVELOPMENT
OF NEW PRODUCTS AND ACCELERATE IN-HOUSE RESEARCH AND DEVELOPMENT
ACTIVITIES
    * PAYMENT AND DELIVERY OF NEW SHARES IS EXPECTED TO TAKE
PLACE ON
5 APRIL 2022
    * AN APPLICATION WILL BE MADE TO ADMIT NEW SHARES TO TRADING
ON
REGULATED MARKET OF EURONEXT BRUSSELS AT SAME TIME
    * COMPANY HAS AGREED WITH UNDERWRITERS TO A CUSTOMARY
180-DAY
STANDSTILL PERIOD ON FUTURE SHARE ISSUANCES, WAIVABLE BY
UNDERWRITERS AND SUBJECT TO CUSTOMARY EXCEPTIONS

Source text for Eikon:  urn:newsml:reuters.com:*:nGNE9GWQ4R
Further company coverage:  HYL.BR 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 772 09 20;))

Recent news on Hyloris Pharmaceuticals SA

See all news